Literature DB >> 31745637

Endometriosis and risk of ovarian cancer: what do we know?

Milena Králíčková1,2,3, Antonio Simone Laganà4, Fabio Ghezzi4, Vaclav Vetvicka5.   

Abstract

PURPOSE: Despite long and intensive research, endometriosis remains one of the leading causes of morbidity among premenopausal women. The majority of endometriosis-related ovarian carcinomas occur in the presence of atypical ovarian endometriosis. Nevertheless, despite the increased incidence of ovarian cancer in patients with endometriosis, our knowledge of the risk factors and mechanisms is still incomplete.
METHOD: Narrative overview, synthesizing the recent findings of literature retrieved from databases.
RESULTS: Herein, we reviewed and summarized the most recent knowledge regarding endometriosis and ovarian cancer.
CONCLUSION: The evidence showing that patients with endometriosis have a higher risk of developing ovarian cancer is compelling. However, the question of how much higher the absolute risk is, is not fully clear.

Entities:  

Keywords:  Apoptosis; Endometriosis; Immune imbalance; Neoangiogenesis; Ovarian cancer

Mesh:

Year:  2019        PMID: 31745637     DOI: 10.1007/s00404-019-05358-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  17 in total

1.  A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients.

Authors:  Vera Loizzi; Ettore Cicinelli; Vittoria Del Vecchio; Francesca Arezzo; Xheni Deromemaj; Anila Kardhashi; Angelo Paradiso; Francesco Legge; Maria Iole Natalicchio; Leonardo Resta; Nicoletta Resta; Daria Carmela Loconte; Gennaro Cormio
Journal:  Acta Biomed       Date:  2022-08-31

2.  LncRNA PART1 Stimulates the Development of Ovarian Cancer by Up-regulating RACGAP1 and RRM2.

Authors:  Hui Li; Yuansheng Lei; Shuangxue Li; Feng Li; Jieyun Lei
Journal:  Reprod Sci       Date:  2022-05-12       Impact factor: 2.924

Review 3.  Role of ultrasound in the detection of recurrent ovarian cancer: a review of the literature.

Authors:  Andrea Rosati; Salvatore Gueli Alletti; Vito Andrea Capozzi; Mariateresa Mirandola; Virginia Vargiu; Camilla Fedele; Stefano Uccella; Carmine Vascone
Journal:  Gland Surg       Date:  2020-08

4.  Association Between Endometriosis and Prognosis of Ovarian Cancer: An Updated Meta-Analysis.

Authors:  Peng Chen; Chi-Yuan Zhang
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

5.  Integrated analysis of a competing endogenous RNA network reveals an 11-lncRNA prognostic signature in ovarian cancer.

Authors:  Yongjian Zhang; Hu Zhou; Meiyin Zhang; Linan Xing; Chang Yang; Bairong Xia; Ge Lou
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

6.  Identification of core genes for early diagnosis and the EMT modulation of ovarian serous cancer by bioinformatics perspective.

Authors:  Yanna Zhang; Xun Wang; Xiancheng Chen
Journal:  Aging (Albany NY)       Date:  2021-01-25       Impact factor: 5.682

Review 7.  Malignant transformation of hepatic endometriosis: a case report and literature review.

Authors:  Dandan Wang; Qing Yang; Huaitao Wang; Chang Liu
Journal:  BMC Womens Health       Date:  2021-06-21       Impact factor: 2.809

Review 8.  Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives.

Authors:  Costin Vlad Anastasiu; Marius Alexandru Moga; Andrea Elena Neculau; Andreea Bălan; Ioan Scârneciu; Roxana Maria Dragomir; Ana-Maria Dull; Liana-Maria Chicea
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

9.  STAT4 targets KISS1 to promote the apoptosis of ovarian granulosa cells.

Authors:  Yao Jiang; Xiaoping Xin; Xiangchun Pan; Ailing Zhang; Zhe Zhang; Jiaqi Li; Xiaolong Yuan
Journal:  J Ovarian Res       Date:  2020-11-20       Impact factor: 4.234

Review 10.  The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art.

Authors:  Dorota Suszczyk; Wiktoria Skiba; Joanna Jakubowicz-Gil; Jan Kotarski; Iwona Wertel
Journal:  Cells       Date:  2021-03-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.